Sai‐Ching J. Yeung

12.3k total citations · 1 hit paper
237 papers, 8.5k citations indexed

About

Sai‐Ching J. Yeung is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sai‐Ching J. Yeung has authored 237 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Oncology, 90 papers in Molecular Biology and 43 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sai‐Ching J. Yeung's work include Cancer-related Molecular Pathways (24 papers), Metabolism, Diabetes, and Cancer (20 papers) and Ubiquitin and proteasome pathways (18 papers). Sai‐Ching J. Yeung is often cited by papers focused on Cancer-related Molecular Pathways (24 papers), Metabolism, Diabetes, and Cancer (20 papers) and Ubiquitin and proteasome pathways (18 papers). Sai‐Ching J. Yeung collaborates with scholars based in United States, China and Netherlands. Sai‐Ching J. Yeung's co-authors include Mong‐Hong Lee, Jingxuan Pan, Liem Phan, James L. Abbruzzese, Manal M. Hassan, Marina Konopleva, Donghui Li, Xuexin He, Lawrence Chan and Aiham Qdaisat and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Sai‐Ching J. Yeung

225 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study

2022 145 citations Kai Li, Yusheng Lin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sai‐Ching J. Yeung United States	46	4.7k	3.2k	2.1k	1.1k	967	237	8.5k
Gaetano De Rosa Italy	46	2.7k 0.6×	3.0k 1.0×	1.0k 0.5×	1.5k 1.3×	1.4k 1.4×	349	8.9k
Yun Qiu China	47	3.5k 0.7×	1.4k 0.4×	1.1k 0.5×	1.2k 1.0×	739 0.8×	164	8.0k
Marc K. Halushka United States	56	4.4k 0.9×	1.8k 0.6×	2.2k 1.0×	776 0.7×	1.7k 1.7×	215	11.8k
R. Daniel Beauchamp United States	61	5.1k 1.1×	3.9k 1.2×	2.1k 1.0×	724 0.6×	1.8k 1.8×	179	11.4k
Gary M. Tse Hong Kong	57	2.4k 0.5×	3.6k 1.1×	3.4k 1.6×	693 0.6×	1.8k 1.9×	324	11.4k
Tsutomu Masaki Japan	47	3.4k 0.7×	1.9k 0.6×	1.5k 0.7×	1.7k 1.4×	2.3k 2.4×	521	9.7k
J. Joshua Smith United States	51	3.4k 0.7×	3.6k 1.1×	1.3k 0.6×	900 0.8×	2.1k 2.2×	248	10.7k
Lorraine O’Driscoll Ireland	47	5.4k 1.2×	1.9k 0.6×	3.0k 1.4×	544 0.5×	694 0.7×	136	9.1k
Wolfgang Jelkmann Germany	58	3.4k 0.7×	1.3k 0.4×	3.1k 1.4×	696 0.6×	684 0.7×	212	11.8k
Javid J. Moslehi United States	68	3.7k 0.8×	6.6k 2.1×	1.3k 0.6×	973 0.8×	1.2k 1.2×	211	16.0k

Countries citing papers authored by Sai‐Ching J. Yeung

Since Specialization

Citations

This map shows the geographic impact of Sai‐Ching J. Yeung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sai‐Ching J. Yeung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sai‐Ching J. Yeung more than expected).

Fields of papers citing papers by Sai‐Ching J. Yeung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sai‐Ching J. Yeung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sai‐Ching J. Yeung. The network helps show where Sai‐Ching J. Yeung may publish in the future.

Co-authorship network of co-authors of Sai‐Ching J. Yeung

This figure shows the co-authorship network connecting the top 25 collaborators of Sai‐Ching J. Yeung. A scholar is included among the top collaborators of Sai‐Ching J. Yeung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sai‐Ching J. Yeung. Sai‐Ching J. Yeung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yeung, Sai‐Ching J., et al.. (2024). A case series of adrenal insufficiency (likely due to hypophysitis) in cancer patients treated with immune checkpoint inhibitors. The American Journal of Emergency Medicine. 80. 227.e1–227.e5. 1 indexed citations

Reyes‐Gibby, Cielito C., et al.. (2024). Antibody-Drug Conjugates: The Toxicities and Adverse Effects That Emergency Physicians Must Know. Annals of Emergency Medicine. 85(3). 214–229. 4 indexed citations

Wang, Lu, Yu‐Sheng Lin, Zhimeng Yao, et al.. (2024). Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases. Drug Resistance Updates. 76. 101118–101118. 5 indexed citations

Li, Kai, Yusheng Lin, Yu Zhou, et al.. (2023). Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study. Gastroenterology. 165(4). 932–945.e9. 40 indexed citations

Chaftari, Patrick, et al.. (2021). The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review. SHILAP Revista de lepidopterología. 5(1). 13–25. 9 indexed citations

He, Xuexin, Jiali Ji, Aiham Qdaisat, et al.. (2021). Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors. Clinical Cancer Research. 27(19). 5343–5352. 8 indexed citations

Wang, Shuhong, Yusheng Lin, Xiao Xiong, et al.. (2020). Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial. Clinical Cancer Research. 26(18). 4921–4932. 119 indexed citations

He, Xuexin, Jiali Ji, Mei Tian, et al.. (2019). Long-Term Survival Analysis of Adjuvant Chemotherapy with or without Trastuzumab in Patients with T1, Node-Negative HER2-Positive Breast Cancer. Clinical Cancer Research. 25(24). 7388–7395. 15 indexed citations

Lin, Yusheng, Hongmei Dong, Wan‐Wan Lin, et al.. (2019). Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma. Clinical Cancer Research. 25(10). 3035–3045. 79 indexed citations

10.

Elsayem, Ahmed, Éduardo Bruera, Alan Valentine, et al.. (2017). Advance Directives, Hospitalization, and Survival Among Advanced Cancer Patients with Delirium Presenting to the Emergency Department: A Prospective Study. The Oncologist. 22(11). 1368–1373. 12 indexed citations

11.

Elsayem, Ahmed, Éduardo Bruera, Alan Valentine, et al.. (2016). Delirium frequency among advanced cancer patients presenting to an emergency department: A prospective, randomized, observational study. Cancer. 122(18). 2918–2924. 25 indexed citations

12.

Phan, Liem, Enrique Fuentes‐Mattei, Weixin Wu, et al.. (2015). Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Research. 75(19). 4131–4142. 34 indexed citations

13.

Bankson, James A., Christopher M. Walker, Marc S. Ramirez, et al.. (2015). Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. Cancer Research. 75(22). 4708–4717. 70 indexed citations

14.

Xue, Yuwen, Jian Chen, Liem Phan, et al.. (2012). HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle. 11(22). 4181–4190. 28 indexed citations

15.

Sadeghi, Navid, James L. Abbruzzese, Sai‐Ching J. Yeung, Manal M. Hassan, & Donghui Li. (2012). Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer. Clinical Cancer Research. 18(10). 2905–2912. 245 indexed citations

16.

Wu, Yongbin, Xiaoyong Sun, Xianping Shi, et al.. (2012). Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth Factor Receptor α and Bcr-Abl Oncogene Addiction in Malignant Hematologic Cells. Clinical Cancer Research. 18(7). 1966–1978. 42 indexed citations

17.

Su, Chun‐Hui, Ruiying Zhao, Fanmao Zhang, et al.. (2010). 14-3-3σ Exerts Tumor-Suppressor Activity Mediated by Regulation of COP1 Stability. Cancer Research. 71(3). 884–894. 50 indexed citations

18.

Pan, Jingxuan, et al.. (2005). Bcl-2-Associated X Protein Is the Main Mediator of Manumycin A-Induced Apoptosis in Anaplastic Thyroid Cancer Cells. The Journal of Clinical Endocrinology & Metabolism. 90(6). 3583–3591. 9 indexed citations

19.

Yeung, Sai‐Ching J. & Robert F. Gagel. (2003). Endocrine Paraneoplastic Syndromes (“Ectopic” Hormone Production). Journal of Substance Abuse. 8(4). 431–43. 5 indexed citations

20.

Yeung, Sai‐Ching J., et al.. (2002). High-performance liquid chromatographic assay validation of Manumycin A in mouse plasma. Journal of Chromatography B. 776(2). 177–182. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact